Purification and Biocompatibility of Fermented Hyaluronic Acid for Its Applications to Biomaterials

다국어 초록 (Multilingual Abstract)

Background: Hyaluronic acid (HA) is of importance due to its diverse applications in pharmaceuticals and medical devices such as dermal filler, adhesion barriers, carrier for cells and bioactive molecules as well as scaffold biomaterials for tissue engineering. Evaluations of purification and biocompatibility of HA are required for its applications to biomaterials.
Methods: After synthesizing HA by fermentation of streptococcus zooepidemicus for 25 hr, extensively purification of the fermented broth was performed to remove impurities using a filtration process for insoluble components and cells, and diverse adsorbents for soluble impurities. Its in vitro biocompatibility has been evaluated by measurement of cell counting and assay of cell live and dead.
Results: 60% yield of white HA powder was obtained, having 15-17 dL/g intrinsic viscosity with a molecular weight of approximately 1,000 kDa. While low molecular weight impurities and insoluble impurities were successfully removed using a ultrafiltration membrane with 50 KDa molecular weight cut, endotoxins, high molecular weight proteins and nucleic acids were removed from the broth by employing adsorbents such as alumina and activated carbons. Alumina showed the best results for the removal of endotoxins, all of the activated carbons were very effective in the removal of high molecular weight proteins and nucleic acids. The purified HA solution showed excellent cell compatibility with no cell damages as observed by both measurement of cell proliferation and observation of cell viability.
Conclusions: We obtained high molecular weight HA with excellent biocompatibility as judged by both measurement of cell proliferation and viability, indicating high possibility of its applications to biomaterials.

참고문헌 (Reference)

1 김아람, "온도감응성 입자가 포함된 셀룰로오스 하이드로젤의 생체적합성 평가" 한국생체재료학회 17 (17): 181-186, 2013

2 Burdick JA, "controlled degradation and mechanical behavior of photopolymerized hyalu-ronic acid networks" 6 (6): 386-391, 2005

3 Gojgini S, "Utilizing cell-matrix interactions to modulate gene transfer to stem cells inside hyaluronic acid hydrogels" 8 (8): 1582-1591, 2011

4 Meyer K, "The polysaccharide of the vitreous humor" 107 : 629-634, 1934

5 Akdamar HA, "Separtation and purification of hyaluronic acid by glucuronic acid imprinted microbeads" 29 (29): 1404-1408, 2009

6 Hong SS, "Purification and structure identification of hyaluronic acid" 15 (15): 811-812, 2004

7 Volpi N, "Purification and characterization of hyalu-ronic acid from the mollusk bivalve mytilus galloprovincialis" 85 (85): 619-625, 2003

8 Leach JB, "Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineer-ing scaffolds" 82 (82): 578-589, 2003

9 Chong BF, "Microbial hyalu-ronic acid production" 66 (66): 341-351, 2005

10 d’Ayala GG, "Marine Derived Polysaccharides for Biomedical Applications: Chemical Modifica-tion Approaches" 13 (13): 2069-2106, 2008

11 Tawada A, "Large-scale preparation, purification, and characterization of hyaluronan oligosaccharides from 4-mers to 52-mers" 12 (12): 421-426, 2002

12 Burdick JA, "Hyaluronic acid hydrogels for bio-medical applications" 23 (23): 41-56, 2011

13 Choh SY, "Facile synthesis and characteriza-tion of disulfide-cross-linked hyaluronic acid hydrogels for protein delivery and cell encapsulation" 12 (12): 1126-1136, 2011

14 Kang DY, "Extraction of hyalu-ronic acid (HA) from rooster comb and characterization using flow field-flow fractionation (FlFFF) coupled with multiangle light scattering (MALS)" 33 (33): 3530-3536, 2010

15 Pasquale MD, "Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study" 27 (27): 1126-1130, 2008

16 Luo Y, "Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery" 69 (69): 169-184, 2000

17 Kablik J, "Com-parative physical properties of hyaluronic acid dermal fillers" 35 (35): 302-312, 2009

18 Kim J, "Characterization of low molecular weight hyalu-ronic acid based hydrogel and differential stem cell responses in the hydrogel microenvironments" 88A (88A): 967-975, 2009

19 Johnson P, "CD44 and its role in inflammation and inflammatory diseases" 8 (8): 208-220, 2009

20 Kim J, "Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein -2 and human mesen-chymal stem cell" 28 (28): 1830-1837, 2007

21 Hahn SK, "Anti-inflammatory drug delivery from hyaluronic acid hydrogels" 15 (15): 1111-1119, 2004

22 Awesh KY, "An insight on hyaluronic acid in drug targeting and drug delivery" 16 (16): 91-107, 2008

23 Rangaswamy V, "An efficient process for production and purification of hyaluronic acid from streptococcus equi subsp. zooepidemicus" 30 (30): 493-496, 2008

24 Kendall FE, "A serologically inac-tive polysaccharide elaborated by mucoid strains of group A hemolytic streptococcus" 118 : 61-69, 1937